v3.26.1
EQUITY (Details Narrative) - USD ($)
 12 Months Ended
Aug. 27, 2024
Aug. 16, 2024
Dec. 31, 2025
Dec. 31, 2024
Class of Stock [Line Items]        
Stock repurchase, value       $ 6,294
Amortization expense       2,364
Accrued dividends     $ 324,370 $ 324,370
Common stock, shares authorized     55,000,000 55,000,000
Common stock, par value     $ 0.0001 $ 0.0001
Preferred stock, shares authorized     10,000,000 10,000,000
Preferred stock, par value     $ 0.0001 $ 0.0001
Common stock, shares outstanding     33,372,796 33,372,796
Series C Preferred Stock [Member]        
Class of Stock [Line Items]        
Common stock, shares outstanding     33,372,796 33,372,796
Preferred stock, shares outstanding     1 1
Series D Preferred Stock [Member]        
Class of Stock [Line Items]        
Preferred stock, shares outstanding     270,306 270,306
Series C Convertible Preferred Stock [Member]        
Class of Stock [Line Items]        
Number of shares issued     14,815  
Share price     $ 3.75  
Series D Convertible Preferred Stock [Member]        
Class of Stock [Line Items]        
Share price     $ 2.15  
Cumulative preferred dividend rate     12.00%  
Share Purchase Agreement [Member] | Alvaro Pascual-Leone M.D [Member]        
Class of Stock [Line Items]        
Stock repurchase and cancelled   70,010    
Stock repurchase, value   $ 6,294    
Financial Advisory and Investment Banking Services Agreement [Member]        
Class of Stock [Line Items]        
Number of shares issued 813,971      
Shares issued, value $ 73,257   $ 73,257  
Amortization expense     $ 48,838 $ 24,419